Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification
| dc.contributor.author | Fakhry, Maya | |
| dc.contributor.author | Skafi, Najwa | |
| dc.contributor.author | Fayyad-Kazan, Mohammad | |
| dc.contributor.author | Kobeissy, Firas H. | |
| dc.contributor.author | Hamade, Eva | |
| dc.contributor.author | Mébarek, Saïda | |
| dc.contributor.author | Habib, Aida A. | |
| dc.contributor.author | Borghol, Nada | |
| dc.contributor.author | Zeidan, Asad | |
| dc.contributor.author | Magne, David | |
| dc.contributor.author | Fayyad-kazan, Hussein | |
| dc.contributor.author | Badran, Bassam M. | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.department | Anatomy, Cell Biology, and Physiological Sciences | |
| dc.contributor.department | Division of Cardiology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:37:56Z | |
| dc.date.available | 2025-01-24T11:37:56Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Medial artery calcification, a hallmark of type 2 diabetes mellitus and chronic kidney disease (CKD), is known as an independent risk factor for cardiovascular mortality and morbidity. Hyperphosphatemia associated with CKD is a strong stimulator of vascular calcification but the molecular mechanisms regulating this process remain not fully understood. We showed that calcification was induced after exposing Sprague-Dawley rat aortic explants to high inorganic phosphate level (P i , 6 mM) as examined by Alizarin red and Von Kossa staining. This calcification was associated with high Tissue-Nonspecific Alkaline Phosphatase (TNAP) activity, vascular smooth muscle cells de-differentiation, manifested by downregulation of smooth muscle 22 alpha (SM22α) protein expression which was assessed by immunoblot analysis, immunofluorescence, and trans-differentiation into osteo-chondrocyte-like cells revealed by upregulation of Runt related transcription factor 2 (Runx2), TNAP, osteocalcin, and osteopontin mRNA levels which were determined by quantitative real-time PCR. To unravel the possible mechanism(s) involved in this process, microRNA (miR) expression profile, which was assessed using TLDA technique and thereafter confirmed by individual qRT-PCR, revealed differential expression 10 miRs, five at day 3 and 5 at day 6 post P i treatment versus control untreated aortas. At day 3, miR-200c, -155, 322 were upregulated and miR-708 and 331 were downregulated. After 6 days of treatment, miR-328, -546, -301a were upregulated while miR-409 and miR-542 were downregulated. Our results indicate that high P i levels trigger aortic calcification and modulation of certain miRs. These observations suggest that mechanisms regulating aortic calcification might involve miRs, which warrant further investigations in future studies. © 2017 Wiley Periodicals, Inc. | |
| dc.identifier.doi | https://doi.org/10.1002/jcp.26121 | |
| dc.identifier.eid | 2-s2.0-85034073016 | |
| dc.identifier.pmid | 28776684 | |
| dc.identifier.uri | http://hdl.handle.net/10938/28928 | |
| dc.language.iso | en | |
| dc.publisher | Wiley-Liss Inc. | |
| dc.relation.ispartof | Journal of Cellular Physiology | |
| dc.source | Scopus | |
| dc.subject | Aorta | |
| dc.subject | Calcification | |
| dc.subject | Inorganic phosphate | |
| dc.subject | Micrornas | |
| dc.subject | Trans-differentiation | |
| dc.subject | Alkaline phosphatase | |
| dc.subject | Animals | |
| dc.subject | Calcification, physiologic | |
| dc.subject | Cell dedifferentiation | |
| dc.subject | Core binding factor alpha 1 subunit | |
| dc.subject | Diabetes mellitus, type 2 | |
| dc.subject | Gene expression regulation | |
| dc.subject | Humans | |
| dc.subject | Hyperphosphatemia | |
| dc.subject | Microfilament proteins | |
| dc.subject | Muscle proteins | |
| dc.subject | Muscle, smooth, vascular | |
| dc.subject | Osteocalcin | |
| dc.subject | Phosphates | |
| dc.subject | Rats | |
| dc.subject | Renal insufficiency, chronic | |
| dc.subject | Alpha smooth muscle actin | |
| dc.subject | Messenger rna | |
| dc.subject | Microrna | |
| dc.subject | Microrna 107 | |
| dc.subject | Microrna 133b | |
| dc.subject | Microrna 135a | |
| dc.subject | Microrna 155 | |
| dc.subject | Microrna 186 | |
| dc.subject | Microrna 200c | |
| dc.subject | Microrna 223 | |
| dc.subject | Microrna 296 | |
| dc.subject | Microrna 301a | |
| dc.subject | Microrna 322 | |
| dc.subject | Microrna 323 | |
| dc.subject | Microrna 328 | |
| dc.subject | Microrna 331 | |
| dc.subject | Microrna 345 | |
| dc.subject | Microrna 375 | |
| dc.subject | Microrna 409 | |
| dc.subject | Microrna 491 | |
| dc.subject | Microrna 542 | |
| dc.subject | Microrna 546 | |
| dc.subject | Microrna 598 | |
| dc.subject | Microrna 708 | |
| dc.subject | Osteopontin | |
| dc.subject | Phosphate | |
| dc.subject | Tissue nonspecific alkaline phosphatase | |
| dc.subject | Transcription factor runx2 | |
| dc.subject | Unclassified drug | |
| dc.subject | Actin binding protein | |
| dc.subject | Alpl protein, human | |
| dc.subject | Mirn328 microrna, rat | |
| dc.subject | Muscle protein | |
| dc.subject | Runx2 protein, rat | |
| dc.subject | Transgelin | |
| dc.subject | Alizarin red staining | |
| dc.subject | Animal experiment | |
| dc.subject | Animal tissue | |
| dc.subject | Artery calcification | |
| dc.subject | Article | |
| dc.subject | Cell transdifferentiation | |
| dc.subject | Chondrocyte | |
| dc.subject | Controlled study | |
| dc.subject | Enzyme activity | |
| dc.subject | Explant | |
| dc.subject | Gene expression profiling | |
| dc.subject | Immunoblotting | |
| dc.subject | Male | |
| dc.subject | Nonhuman | |
| dc.subject | Priority journal | |
| dc.subject | Protein expression | |
| dc.subject | Rat | |
| dc.subject | Real time polymerase chain reaction | |
| dc.subject | Sprague dawley rat | |
| dc.subject | Staining | |
| dc.subject | Upregulation | |
| dc.subject | Vascular smooth muscle cell | |
| dc.subject | Von kossa staining | |
| dc.subject | Animal | |
| dc.subject | Bone mineralization | |
| dc.subject | Chronic kidney failure | |
| dc.subject | Drug effect | |
| dc.subject | Genetics | |
| dc.subject | Human | |
| dc.subject | Metabolism | |
| dc.subject | Non insulin dependent diabetes mellitus | |
| dc.subject | Pathology | |
| dc.subject | Pathophysiology | |
| dc.subject | Vascular smooth muscle | |
| dc.title | Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1